Prescribing information

   

Below are a selection of resources to help you and your patients stay on track with PIQRAY® + fulvestrant.

 

Screenshot from the video: Professor Caroline Robert discusses the landmark 5-year data with Tafinlar + Mekinist

THERAPY MANAGEMENT GUIDE

A brochure to provide guidance on the management of specific adverse events that your patients on PIQRAY® + fulvestrant may experience, and how to optimise treatment with appropriate medical management.

Download a digital copy 

 

Preview of 'Your guide to managing pyrexia'

PATIENT MANAGEMENT GUIDE

A booklet for you to share with your patients, to help them understand more about the treatment they have been prescribed.

Download a digital copy  Request a hard copy  

 

Screenshot from the video: Dr Paul Nathan discusses the COMBI-AD trial

JOURNAL REPRINTS 

For relevant journal publications, including a SOLAR-1 study reprint, please contact Novartis.

Download a digital copy

 

Screenshot from the video: Dr Paul Nathan discusses the COMBI-AD trial

PATIENT SUPPORT WEBSITE

A website for patients who have been prescribed this medicine, to allow them to find out more about their treatment with PIQRAY® plus fulvestrant, such as how it works and the side effects they might experience. Please visit www.illuminatingabc.co.uk and use the password: [email protected]

Access the patient website (HCPs only) 

 
HCP20-C004 September 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]